Andere Kunden interessierten sich auch für
![The Pharmaceutical Entrepreneur]( "The Pharmaceutical Entrepreneur")
The Pharmaceutical Entrepreneur68,99 €![Mr DNA]( "Mr DNA")
Mr DNA71,99 €![L'Entrepreneur Pharmaceutique]( "L'Entrepreneur Pharmaceutique")
L'Entrepreneur Pharmaceutique67,99 €![Cosmetic Body Alteration and the Hymenoplasty Procedure]( "Cosmetic Body Alteration and the Hymenoplasty Procedure")
Cosmetic Body Alteration and the Hymenoplasty Procedure28,99 €![Dietary Intake and Nutrition Status of HIV-infected Women in Kenya]( "Dietary Intake and Nutrition Status of HIV-infected Women in Kenya")
Dietary Intake and Nutrition Status of HIV-infected Women in Kenya36,99 €![Care, Need and Crucial Considerations For HIV Infected Individuals]( "Care, Need and Crucial Considerations For HIV Infected Individuals")
Care, Need and Crucial Considerations For HIV Infected Individuals27,99 €![Return-to-Play after Lower Limb Muscle Injury in Football]( "Return-to-Play after Lower Limb Muscle Injury in Football")
Return-to-Play after Lower Limb Muscle Injury in Football75,99 €
The term "ATMs" is understood to refer to both advanced therapy medicinal products that have been granted a marketing authorization and advanced therapy medicinal products that are the subject of clinical trials or are used as a reference in a clinical trial (investigational advanced therapy medicinal product). This guide specifies the GMP requirements that must govern the manufacture of ATMPs that have been granted a marketing authorization and ATMPs used in a clinical trial context. This guide does not apply to medicinal products other than ATMPs. However, the detailed guidelines referred to in the second paragraph of Article 47 of Directive 2001/83/c4 and Article 63(1) of Regulation (EU) No 536/2014 do not apply to ATMPs unless specifically referred to in these guidelines. If specific provisions only concern advanced therapy medicinal products that have been granted a marketing authorization, the term used is "authorized ATMPs".